As of close of business last night, Sotera Health Company’s stock clocked out at $8.00, up 32.89% from its previous closing price of $6.02. In other words, the price has increased by $+1.98 from its previous closing price. On the day, 31980359 shares were traded. SHC stock price reached its highest trading level at $9.60 during the session, while it also had its lowest trading level at $7.65.
To gain a deeper understanding of SHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.95. For the most recent quarter (mrq), Quick Ratio is recorded 2.70 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 2.97 whereas as Long-Term Debt/Eq ratio is at 2.97.
Upgrades & Downgrades
On October 05, 2022, Citigroup Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $25 to $9.
As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.52, and their Forward P/E ratio for the next fiscal year is 7.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.25 while its Price-to-Book (P/B) ratio in mrq is 3.69.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $24.90, while it has fallen to a 52-week low of $5.78. The 50-Day Moving Average of the stock is 7.78, while the 200-Day Moving Average is calculated to be 17.10.
It appears that SHC traded 2.31M shares on average per day over the past three months and 1.67M shares per day over the past ten days. A total of 280.14M shares are outstanding, with a floating share count of 273.64M. Insiders hold about 0.30% of the company’s shares, while institutions hold 88.20% stake in the company. Shares short for SHC as of Oct 13, 2022 were 6.13M with a Short Ratio of 5.79M, compared to 6.4M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.17% and a Short% of Float of 6.19%.
As of right now, 8 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.22 for the current quarter, with a high estimate of $0.23 and a low estimate of $0.21, while EPS last year was $0.21. The consensus estimate for the next quarter is $0.25, with high estimates of $0.26 and low estimates of $0.23.
Analysts are recommending an EPS of between $0.97 and $0.92 for the fiscal current year, implying an average EPS of $0.96. EPS for the following year is $1.09, with 8 analysts recommending between $1.12 and $1.06.
A total of 8 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.02B, while the lowest revenue estimate was $998M, resulting in an average revenue estimate of $1.01B. In the same quarter a year ago, actual revenue was $931.48M, up 8.70% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $1.1B in the next fiscal year. The high estimate is $1.12B and the low estimate is $1.08B. The average revenue growth estimate for next year is up 8.90% from the average revenue estimate for this year.